Advertisement
The study aimed to investigate the clinical implications of RU in distinguishing ARE from tumor progression following SRS for brain metastases. Researchers noticed that Prolonged resolution of RU after SRS may compromise outcomes. Adverse radiation effects (ARE) following stereotactic radiosurgery (SRS) for brain cancer pose a diagnostic challenge due to the difficulty in […]...
Advertisement
Advertisement
Trusted insights straight to your inbox and get the latest updates from OncWeekly
Advertisement
Background Bispecific T-cell engagers (BTEs) are novel agents used to treat hematological malignancies. Early trials were underpowered to define cardiovascular adverse events (CVAE) and no large-scale studies systematically examined the CVAEs associated with BTEs. Methods Leveraging the US …
Background The combination of immune-checkpoint inhibitors and antiangiogenic agents can synergistically modulate the tumor microenvironment and represents a promising treatment option. Here, we evaluated the efficacy and safety of camrelizumab plus famitinib (a receptor tyrosine kinase …
With the global incidence of non-small cell lung cancer (NSCLC) on the rise, the development of innovative treatment strategies is increasingly vital. This review underscores the pivotal role of precision medicine in transforming NSCLC management, …
Introduction: Spinal metastases are common in metastatic cancer, affecting around 40% of patients. The primary treatment involves radiation therapy, transitioning from conventional external beam radiation therapy (EBRT) to stereotactic body radiation therapy (SBRT) for its …
